New Zealand markets close in 1 hour 31 minutes

Intellipharmaceutics International Inc. (IPCIF)

OTC Markets EXMKT - OTC Markets EXMKT Delayed price. Currency in USD
Add to watchlist
0.10000.0000 (0.00%)
At close: 03:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.48M
Enterprise value 4.30M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.05
Price/book (mrq)N/A
Enterprise value/revenue 4.75
Enterprise value/EBITDA -1.08

Trading information

Stock price history

Beta (5Y monthly) 0.46
52-week change 3100.00%
S&P500 52-week change 324.96%
52-week high 30.1400
52-week low 30.0200
50-day moving average 30.0736
200-day moving average 30.0644

Share statistics

Avg vol (3-month) 34.26k
Avg vol (10-day) 3880
Shares outstanding 533.09M
Implied shares outstanding 690.83M
Float 832.51M
% held by insiders 11.76%
% held by institutions 10.00%
Shares short (28 Feb 2019) 4714k
Short ratio (28 Feb 2019) 40.39
Short % of float (28 Feb 2019) 43.35%
Short % of shares outstanding (28 Feb 2019) 43.26%
Shares short (prior month 31 Jan 2019) 4211.76k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 Sept 2018
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 314 Sept 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Nov 2022
Most-recent quarter (mrq)31 Aug 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,601.02%

Management effectiveness

Return on assets (ttm)-107.39%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)904.95k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)260.40%
Gross profit (ttm)N/A
EBITDA -2.41M
Net income avi to common (ttm)-3.17M
Diluted EPS (ttm)-0.0900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)400.1k
Total cash per share (mrq)0.01
Total debt (mrq)2.22M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.06
Book value per share (mrq)-0.39

Cash flow statement

Operating cash flow (ttm)120.45k
Levered free cash flow (ttm)1.07M